Better together: Spatial arrangement of three immune cells is key to attacking tumors, study finds

by Matthew Tontonoz,Memorial Sloan Kettering Cancer CenterGraphical abstract. Credit:Cancer Cell(2024). DOI: 10.1016/j.ccell.2024.05.025There's a frustrating fact about today&#39

Updated on: July 17,2024 0

Better together: Spatial arrangement of three immune cells is key to attacking tumors, study finds

by Matthew Tontonoz,Memorial Sloan Kettering Cancer CenterGraphical abstract. Credit:Cancer Cell(2024). DOI: 10.1016/j.ccell.2024.05.025There's a frustrating fact about today&#39

Updated on:July 17,2024 0

Unlocking the mystery of preexisting drug resistance: Study sheds light on cancer evolution

byCase Western Reserve UniversityIllustrated abstraction demonstrating how frequency-dependent ecological interactions might increase the likelihood of preexisting resistance. Credit:PRX L

Updated on: July 17,2024 0

Unlocking the mystery of preexisting drug resistance: Study sheds light on cancer evolution

byCase Western Reserve UniversityIllustrated abstraction demonstrating how frequency-dependent ecological interactions might increase the likelihood of preexisting resistance. Credit:PRX L

Updated on:July 17,2024 0

Cancer is the biggest health concern among the public, poll reveals

Cancer is the biggest health concern among the public, poll revealsbyUniversity of CambridgeCredit: Pixabay/CC0 Public DomainTwo-thirds of the public say they are very or somewhat worried about

Updated on: July 17,2024 0

Cancer is the biggest health concern among the public, poll reveals

Cancer is the biggest health concern among the public, poll revealsbyUniversity of CambridgeCredit: Pixabay/CC0 Public DomainTwo-thirds of the public say they are very or somewhat worried about

Updated on:July 17,2024 0

New biomarker shows potential to evaluate treatment response for metastatic colorectal cancer

by Germans Trias i Pujol Research InstituteGraphical abstract. Credit:Biomedicine & Pharmacotherapy(2024). DOI: 10.1016/j.biopha.2024.116857Colorectal cancer is the second leading caus

Updated on: July 17,2024 0

New biomarker shows potential to evaluate treatment response for metastatic colorectal cancer

by Germans Trias i Pujol Research InstituteGraphical abstract. Credit:Biomedicine & Pharmacotherapy(2024). DOI: 10.1016/j.biopha.2024.116857Colorectal cancer is the second leading caus

Updated on:July 17,2024 0

Entering the golden age for antibody-drug conjugates in gynecologic cancer

by Impact Journals LLCCredit: Pixabay/CC0 Public DomainIn an editorial, published inOncosciencetitled, "Entering the golden age for antibody-drug conjugates in gynecologic cancer,&quo

Updated on: July 17,2024 0

Entering the golden age for antibody-drug conjugates in gynecologic cancer

by Impact Journals LLCCredit: Pixabay/CC0 Public DomainIn an editorial, published inOncosciencetitled, "Entering the golden age for antibody-drug conjugates in gynecologic cancer,&quo

Updated on:July 17,2024 0

Clarifying a synergistic effect between different types of antibodies in cancer treatment

by Kindai UniversityA study by researchers from Japan has revealed that the simultaneous administration of two antibodies with different isotypes targeting a specific membrane protein produced a syner

Updated on: July 17,2024 0

Clarifying a synergistic effect between different types of antibodies in cancer treatment

by Kindai UniversityA study by researchers from Japan has revealed that the simultaneous administration of two antibodies with different isotypes targeting a specific membrane protein produced a syner

Updated on:July 17,2024 0

New imaging guidelines for head and neck cancers, a step toward practice change

byUniversity of OklahomaCredit: Unsplash/CC0 Public DomainNewlypublishedresearch inThe Lancet Oncologylays the foundation for many patients with head and neck cancers to

Updated on: July 17,2024 0

New imaging guidelines for head and neck cancers, a step toward practice change

byUniversity of OklahomaCredit: Unsplash/CC0 Public DomainNewlypublishedresearch inThe Lancet Oncologylays the foundation for many patients with head and neck cancers to

Updated on:July 17,2024 0

A treatment for metastasis? Using ferroptosis to attack migrating cancer cells

byFriedrich–Alexander University Erlangen–NurnbergZeb1 regulates the expression of enzymes crucial for adjusting the PUFA:MUFA ratio in phospholipids. Credit:Nature Cell Biology(2024

Updated on: July 17,2024 0

A treatment for metastasis? Using ferroptosis to attack migrating cancer cells

byFriedrich–Alexander University Erlangen–NurnbergZeb1 regulates the expression of enzymes crucial for adjusting the PUFA:MUFA ratio in phospholipids. Credit:Nature Cell Biology(2024

Updated on:July 17,2024 0

Comparison of FDG-PET/CT and CT for treatment evaluation of patients with unresectable malignant pleural mesothelioma

by Impact Journals LLCEpithelioid MPM, stage IIIB (cT4N0M0), woman, 64 years old. Credit:Oncotarget(2024). DOI: 10.18632/oncotarget.28594A new research paper titled "Comparison of FDG

Updated on: July 17,2024 0

Comparison of FDG-PET/CT and CT for treatment evaluation of patients with unresectable malignant pleural mesothelioma

by Impact Journals LLCEpithelioid MPM, stage IIIB (cT4N0M0), woman, 64 years old. Credit:Oncotarget(2024). DOI: 10.18632/oncotarget.28594A new research paper titled "Comparison of FDG

Updated on:July 17,2024 0

Gene set identifies glioblastomas most vulnerable to promising therapeutic

by Becky Ham,Translational Genomics Research InstituteGlioblastoma (histology slide). Credit: Wikipedia/CC BY-SA 3.0Researchers from TGen, part of City of Hope, and from the University of Califo

Updated on: July 17,2024 0

Gene set identifies glioblastomas most vulnerable to promising therapeutic

by Becky Ham,Translational Genomics Research InstituteGlioblastoma (histology slide). Credit: Wikipedia/CC BY-SA 3.0Researchers from TGen, part of City of Hope, and from the University of Califo

Updated on:July 17,2024 0

Trial of cell-based therapy for high-risk lymphoma leads to FDA breakthrough designation

by Krista Conger,Stanford UniversityScanning electron micrograph of a human T lymphocyte (also called a T cell) from the immune system of a healthy donor. Credit: NIAIDCAR-T cell therapy, which

Updated on: July 17,2024 0

Trial of cell-based therapy for high-risk lymphoma leads to FDA breakthrough designation

by Krista Conger,Stanford UniversityScanning electron micrograph of a human T lymphocyte (also called a T cell) from the immune system of a healthy donor. Credit: NIAIDCAR-T cell therapy, which

Updated on:July 17,2024 0

The Sweet Dilemma: Fructose's Impact on Cancer and Immunity

Updated on: July 13,2024 0

The Sweet Dilemma: Fructose's Impact on Cancer and Immunity

Updated on:July 13,2024 0